Loading...
Effect of asymmetric dimethylarginine (ADMA) on heart failure development
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases that limits nitric oxide bioavailability and can increase production of NOS derived reactive oxidative species. Increased plasma ADMA is a one of the strongest predictors of mortality in patients who have had a m...
Na minha lista:
| Udgivet i: | Nitric Oxide |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5017793/ https://ncbi.nlm.nih.gov/pubmed/26923818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.niox.2016.02.006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|